Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,096 | 1,592 | 7,205 | 5,628 | 3,808 |
| Depreciation Amortization | 287 | 143 | 591 | 447 | 297 |
| Income taxes - deferred | N/A | N/A | -46 | -165 | -165 |
| Accounts receivable | 361 | 293 | 365 | 147 | -145 |
| Accounts payable and accrued liabilities | -13 | 182 | 25 | 151 | 34 |
| Other Working Capital | -829 | 642 | 27 | -71 | -651 |
| Other Operating Activity | -417 | -495 | -405 | -217 | -97 |
| Operating Cash Flow | $2,485 | $2,357 | $7,762 | $5,920 | $3,081 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -265 | -83 | -274 | -189 | -123 |
| Purchase Of Investment | -1,300 | -1,300 | -2,650 | -2,250 | -1,150 |
| Sale Of Investment | 1,016 | N/A | 7,792 | 1,908 | 1,351 |
| Purchase Sale Intangibles | -3 | -3 | -13 | -6 | -6 |
| Other Investing Activity | -3 | -3 | -12 | -5 | -6 |
| Investing Cash Flow | $-552 | $-1,386 | $4,856 | $-536 | $72 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -326 | -231 | -1,917 | -1,502 | -1,012 |
| Common Stock Issued | 31 | 25 | 224 | 224 | 147 |
| Common Stock Repurchased | -116 | N/A | -7,792 | -1,908 | -1,351 |
| Dividend Paid | -830 | N/A | -4,329 | -2,625 | -1,754 |
| Other Financing Activity | 6 | 4 | 42 | 51 | 40 |
| Financing Cash Flow | $-1,235 | $-202 | $-13,772 | $-5,760 | $-3,930 |
| Exchange Rate Effect | 7 | -11 | 1 | 9 | 44 |
| Beginning Cash Position | 97 | 97 | 1,251 | 1,251 | 1,251 |
| End Cash Position | 802 | 855 | 97 | 883 | 518 |
| Net Cash Flow | $705 | $758 | $-1,153 | $-367 | $-733 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,485 | 2,357 | 7,762 | 5,920 | 3,081 |
| Capital Expenditure | -265 | -83 | -274 | -189 | -123 |
| Free Cash Flow | 2,220 | 2,274 | 7,488 | 5,731 | 2,958 |